tiprankstipranks
Trending News
More News >
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Advertisement

Infant Bacterial Therapeutics AB (9IB) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Infant Bacterial Therapeutics AB
€5.52
€71.03M
-8.09
84.00%
Xbrane Biopharma AB
kr10.11
€217.39M
1.17
-61.49%
0 Buy
0 Hold
0 Sell
Hold
Ascelia Pharma AB
kr3.00
€390.59M
-2.68
27.60%
Guard Therapeutics International AB
kr1.46
€28.23M
-0.16
-93.53%
Immunicum AB
kr5.75
kr322.92M
-35.98%
Cantargia AB
kr2.42
kr815.45M
-4.15
70.31%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:9IB
Infant Bacterial Therapeutics AB
5.52
2.34
73.58%
SE:XBRANE
Xbrane Biopharma AB
10.11
-15.77
-60.93%
SE:ACE
Ascelia Pharma AB
3.01
0.36
13.40%
SE:GUARD
Guard Therapeutics International AB
1.47
-20.40
-93.30%
SE:IMMU
Immunicum AB
6.59
-3.16
-32.40%
SE:CANTA
Cantargia AB
3.28
1.33
68.47%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis